此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Asenapine in the Treatment of Older Adults With Bipolar Disorder

2014年12月8日 更新者:Martha Sajatovic、University Hospitals Cleveland Medical Center

Objectives: The investigators propose a first-ever, prospective trial of asenapine in older adults with bipolar disorder (BD) to evaluate effects on mood symptoms, tolerability and functional/general health status. Given the dearth of treatment data on older adults with BD, findings are likely to be of substantial clinical interest, may inform larger future studies and will assist in refining bipolar treatment recommendations.

Hypotheses:

Primary: Asenapine therapy will be associated with reduced bipolar manic and depressive symptoms in older adults with BD.

Secondary: Asenapine therapy will be associated with improved functional and general health status, improved global psychopathology, and good tolerability in older adults with BD.

研究概览

地位

完全的

条件

干预/治疗

研究类型

介入性

注册 (实际的)

15

阶段

  • 第四阶段

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Ohio
      • Cleveland、Ohio、美国、44106
        • University Hospitals Case Medical Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

60年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Subjects must have type I Bipolar disorder by DSM-IV criteria confirmed on the Mini Neuropsychiatric Interview (MINI)
  • Subjects must be age 60 or older
  • Subjects must have sub-optimal response to current psychotropic management including at least one of the following:

    1. Behaviors and symptoms of irritability, agitation, mood lability or diminished ability to interact with others in their place of residence
    2. Diminished ability to take care of basic personal needs in their place of residence due to symptoms of BD

Exclusion Criteria:

  • History of intolerance or resistance to asenapine
  • Clinical diagnosis of dementia or Mini-mental state (MMSE) < 24
  • History of TIA, stroke or MI within the past 12 months
  • Medical illness that is the clear, underlying etiology of BD
  • Unstable medical illness or condition including prolonged QT interval, which in the opinion of the study investigators, is likely to affect the outcome of the study or the subject's safety
  • DSM-IV substance dependence (except nicotine or caffeine) within the past 3 months.
  • Rapid cycling BD defined as 4 or more discrete mood episodes within the previous 12 months.
  • At high risk for self-harm or suicide

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
实验性的:Asenapine
12-weeks of open-label asenapine treatment
Asenapine will be administered open-label in pill form. Asenapine will be initiated at 5 mg twice a day and increased as tolerated to a maximum of 20 mg/day. It is anticipated that maximum stable dosing will be achieved by 4 weeks of treatment, although dosage may be reduced due to tolerability concerns at the discretion of the treating research psychiatrist.
其他名称:
  • 萨弗里斯

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Change in Depressive Symptoms as Measured by the Hamilton Depression Rating Scale (HAM-D)
大体时间:Baseline and 12 weeks
The minimum possible score is 0 and the maximum score is 52. A higher score implies a worse condition.
Baseline and 12 weeks
Change in Manic Symptoms as Measured by the Young Mania Rating Scale (YMRS)
大体时间:Baseline and 12 weeks
The minimum possible score is 0 and the maximum score is 60. A higher score implies a worse condition.
Baseline and 12 weeks

次要结果测量

结果测量
措施说明
大体时间
Change in Global Psychopathology as Measured by the Clinical Global Impression Scale for Use in Bipolar Illness (CGI-BP)
大体时间:Baseline and 12 weeks

The minimum possible score is 1 and the maximum score is 7. A higher score implies a worse condition.

The CGI-BP has three scores - Mania Severity, Depression Severity, and Overall Bipolar Illness Severity.

Baseline and 12 weeks
Change in Perception of Physical Health as Measured by the Short Form General Health Survey (SF-12)
大体时间:Baseline and 12 weeks
The minimum possible score is 1 and the maximum score is 99. A higher score implies a better perceived condition.
Baseline and 12 weeks
Change in Perception of Mental Health as Measured by the Short Form General Health Survey (SF-12)
大体时间:Baseline and 12 weeks
The minimum possible score is 1 and the maximum score is 99. A higher score implies a better perceived condition.
Baseline and 12 weeks
Change in Depressive Symptoms as Measured by the Montgomery Asberg Depression Rating Scale (MADRS)
大体时间:Baseline and 12 weeks
The minimum possible score is 0 and the maximum score is 60. A higher score implies a worse condition.
Baseline and 12 weeks
Change in Bipolar Disorder Symptoms as Measured by the Brief Psychiatric Rating Scale (BPRS)
大体时间:Baseline and 12 weeks
The minimum possible score is 18 and the maximum score is 126. A higher score implies a worse condition.
Baseline and 12 weeks
Change in Cognitive Status as Measured by the Stroop Task
大体时间:Baseline and 12 weeks
The Stroop evaluates patients for cognitive functioning. Patients are to read words aloud or name colors as quickly as possible in a 45-second period. The measure contains three tasks, each associated with a subscale as follows: Word, Color, and Color-Word. Each subscale contains 100 items. The raw score range for each of the subscales is 0-100. Each raw subscale score is converted to a T-Score. The possible T-Score range for the Word subscale is 15 to 85. The possible T-Score range for the Color subscale is 8 to 92. The possible T-Score range for the Color-Word subscale is 3 to 98. Higher scores on the subscales indicate better cognitive functioning. Subscales are scored independently and are not added to produce a total score.
Baseline and 12 weeks
Change in Cognitive Status as Measured by the Trail Making Test
大体时间:Baseline and 12 weeks
The Trails test is a measure of cognitive functioning. The measure consists of two parts: A and B. In part A, participants are asked to draw a trail connecting a series of numbers in sequential order. In Part B, participants are asked to draw a trail connecting a combination of letters and numbers. The time taken to complete each task is noted as the score (e.g., 78 seconds). For Trails A, there is no upper limit on the score, as subjects are given as much time as is needed for them to complete the task. Higher scores indicate poorer cognitive functioning. In Trails B, the task is timed with an upper limit of five minutes. If, at four minutes, it is determined that the subject will not likely complete the task in the time allotted, then the task can be called off. Higher scores indicate poorer cognitive functioning.
Baseline and 12 weeks
Change in Cognitive Status as Measured by the Hopkins Verbal Learning Test (HVLT)
大体时间:Baseline and 12 weeks

Evaluates cognitive functioning across domains: recall, delayed recall, retention, recognition (each scored separately). The scores given are titled: recall score, delayed recall score, retention score, recognition discrimination index. Total Recall score = items correctly recalled (0-36). Delayed Recall score = items correctly recalled following delay (0-12). Retention score = percent items recalled that were also recalled after delay (0-100). The Recognition Discrimination score = true positives minus false positives (0-12). Recall task has 12 words and involves to recall of words after all of them are read aloud to the patient. Delayed recall tasks involves the same twelve words, except recall is tasked after a 20-25 minute delay. Recognition task has 24 words. Patient evaluated on how many from original list he or she is able to recognize. Higher scores = better outcomes.

Total recall scores appear in this entry below.

Baseline and 12 weeks
Change in Cognitive Status as Measured by the Dementia Rating Scale (DRS)
大体时间:Baseline and 12 weeks
The DRS contains items that evaluate cognitive function across 5 subscales: attention, initiation/perseveration, construction, conceptualization, and memory. Subscale raw score ranges are: attention (0-37), initiation/perseveration (0-37), construction (0-6), conceptualization (0-39), and memory (0-25). Raw subscale scores are added for a total raw score with range 0-144. For each raw subscale score, scaled scores are looked up from a battery of 13 tables. Age of the participant determines which table is to be used. Total raw subscale score also has its own scaled score in the tables. In addition to use in determining scaled scores for each of the subscales, these tables are used to look up the scaled score for the total raw score. The tables are contained in the article Robust and Expanded Norms for the Dementia Rating Scale (Pedraza, Lucas, et al. 2010); Archives of Clinical Neuropsychology 25; 347-358. Higher scores, raw and scaled, indicate better cognitive functioning.
Baseline and 12 weeks
World Health Organization Disability Assessment Scale (WHO-DAS)
大体时间:12 weeks
The WHO-DAS II is used to assess patients for difficulties that they experience due to health conditions. Six subscales are represented which cover the following domains: Getting Around (range 1-10), Self Care (range 1-10), Life Activities (range 1-20), Understand/Communicate (range 1-10), Participation in Society (range 1-10), and Getting Along with People (range 1-10). Lower scores represent more positive outcomes, while higher scores represent worse outcomes. Total summary scores were not computed for our analyses and is optional for the measure.
12 weeks
Barnes Drug-induced Akathisia Rating Scale (BARS)
大体时间:Baseline and 12 weeks
This scale is used to measure the presence of akathisia, as may result from use of certain psychotropic medications. The scale contains four items and the score for each item is added to produce the total score. Total scores range from 0 to 14. Higher scores indicate more adverse outcomes.
Baseline and 12 weeks
Assessment of Motor Control Abnormality as Measured by the Simpson Angus Scale (SAS)
大体时间:Baseline and 12 weeks
The Simpson-Angus Scale is used to monitor for neurological and musculoskeletal side effects that may be a result of certain psychotropic medications. The scale consists of 10 questions which each can be rated on a scale of 0 to 4. Scores for each item are added to produce a total score. The highest possible total score is 40. Higher scores indicate more adverse outcomes.
Baseline and 12 weeks
Change in Cognitive Status as Measured by the Hopkins Verbal Learning Test (HVLT)
大体时间:Baseline and 12 weeks

Evaluates cognitive functioning across domains: recall, delayed recall, retention, recognition (each scored separately). The scores given are titled: recall score, delayed recall score, retention score, recognition discrimination index. Total Recall score = items correctly recalled (0-12). Delayed Recall score = items correctly recalled following delay (0-12). Retention score = percent items recalled that were also recalled after delay (0-100). The Recognition Discrimination score = true positives minus false positives (0-12). Recall task has 12 words and involves to recall of words after all of them are read aloud to the patient. Delayed recall tasks involves the same twelve words, except recall is tasked after a 20-25 minute delay. Recognition task has 24 words. Patient evaluated on how many from original list he or she is able to recognize. Higher scores = better outcomes.

Delayed recall scores appear in this entry below.

Baseline and 12 weeks
Change in Cognitive Status as Measured by the Hopkins Verbal Learning Test (HVLT)
大体时间:Baseline and 12 weeks

Evaluates cognitive functioning across domains: recall, delayed recall, retention, recognition (each scored separately). The scores given are titled: recall score, delayed recall score, retention score, recognition discrimination index. Total Recall score = items correctly recalled (0-12). Delayed Recall score = items correctly recalled following delay (0-12). Retention score = percent items recalled that were also recalled after delay (0-100). The Recognition Discrimination score = true positives minus false positives (0-12). Recall task has 12 words and involves to recall of words after all of them are read aloud to the patient. Delayed recall tasks involves the same twelve words, except recall is tasked after a 20-25 minute delay. Recognition task has 24 words. Patient evaluated on how many from original list he or she is able to recognize. Higher scores = better outcomes.

Retention scores appear in this entry below.

Baseline and 12 weeks
Change in Cognitive Status as Measured by the Hopkins Verbal Learning Test (HVLT)
大体时间:Baseline and 12 weeks

Evaluates cognitive functioning across domains: recall, delayed recall, retention, recognition (each scored separately). The scores given are titled: recall score, delayed recall score, retention score, recognition discrimination index. Total Recall score = items correctly recalled (0-12). Delayed Recall score = items correctly recalled following delay (0-12). Retention score = percent items recalled that were also recalled after delay (0-100). The Recognition Discrimination score = true positives minus false positives (0-12). Recall task has 12 words and involves to recall of words after all of them are read aloud to the patient. Delayed recall tasks involves the same twelve words, except recall is tasked after a 20-25 minute delay. Recognition task has 24 words. Patient evaluated on how many from original list he or she is able to recognize. Higher scores = better outcomes.

Recognition Discrimination Index appears in this entry below

Baseline and 12 weeks

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Martha Sajatovic, M.D.、University Hospitals Cleveland Medical Center

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2011年10月1日

初级完成 (实际的)

2014年3月1日

研究完成 (实际的)

2014年3月1日

研究注册日期

首次提交

2011年10月24日

首先提交符合 QC 标准的

2011年10月24日

首次发布 (估计)

2011年10月26日

研究记录更新

最后更新发布 (估计)

2014年12月30日

上次提交的符合 QC 标准的更新

2014年12月8日

最后验证

2014年12月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅